172 related articles for article (PubMed ID: 19482555)
1. Changes in autoreactive T cell avidity during type 1 diabetes development.
Standifer NE; Burwell EA; Gersuk VH; Greenbaum CJ; Nepom GT
Clin Immunol; 2009 Sep; 132(3):312-20. PubMed ID: 19482555
[TBL] [Abstract][Full Text] [Related]
2. Antigen-specific immunomodulation for type 1 diabetes by novel recombinant antibodies directed against diabetes-associates auto-reactive T cell epitope.
Dahan R; Gebe JA; Preisinger A; James EA; Tendler M; Nepom GT; Reiter Y
J Autoimmun; 2013 Dec; 47():83-93. PubMed ID: 24090977
[TBL] [Abstract][Full Text] [Related]
3. A low antigen dose selectively promotes expansion of high-avidity autoreactive T cells with distinct phenotypic characteristics: a study of human autoreactive CD4+T cells specific for GAD65.
Oling V; Geubtner K; Ilonen J; Reijonen H
Autoimmunity; 2010 Dec; 43(8):573-82. PubMed ID: 20370569
[TBL] [Abstract][Full Text] [Related]
4. Soluble, dimeric HLA DR4-peptide chimeras: an approach for detection and immunoregulation of human type-1 diabetes.
Preda I; McEvoy RC; Lin M; Bona CA; Rapaport R; Brumeanu TD; Casares S
Eur J Immunol; 2005 Sep; 35(9):2762-75. PubMed ID: 16106371
[TBL] [Abstract][Full Text] [Related]
5. Autoantigen-specific memory CD4+ T cells are prevalent early in progression to Type 1 diabetes.
Oling V; Reijonen H; Simell O; Knip M; Ilonen J
Cell Immunol; 2012; 273(2):133-9. PubMed ID: 22270037
[TBL] [Abstract][Full Text] [Related]
6. High diversity in the TCR repertoire of GAD65 autoantigen-specific human CD4+ T cells.
Eugster A; Lindner A; Catani M; Heninger AK; Dahl A; Klemroth S; Kühn D; Dietz S; Bickle M; Ziegler AG; Bonifacio E
J Immunol; 2015 Mar; 194(6):2531-8. PubMed ID: 25681349
[TBL] [Abstract][Full Text] [Related]
7. CD4(+) T cells from glutamic acid decarboxylase (GAD)65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transfer.
Tarbell KV; Lee M; Ranheim E; Chao CC; Sanna M; Kim SK; Dickie P; Teyton L; Davis M; McDevitt H
J Exp Med; 2002 Aug; 196(4):481-92. PubMed ID: 12186840
[TBL] [Abstract][Full Text] [Related]
8. GAD65-specific CD4+ T-cells with high antigen avidity are prevalent in peripheral blood of patients with type 1 diabetes.
Reijonen H; Mallone R; Heninger AK; Laughlin EM; Kochik SA; Falk B; Kwok WW; Greenbaum C; Nepom GT
Diabetes; 2004 Aug; 53(8):1987-94. PubMed ID: 15277377
[TBL] [Abstract][Full Text] [Related]
9. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC
J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878
[TBL] [Abstract][Full Text] [Related]
10. Autoreactive human T-cell receptor initiates insulitis and impaired glucose tolerance in HLA DR4 transgenic mice.
Gebe JA; Unrath KA; Yue BB; Miyake T; Falk BA; Nepom GT
J Autoimmun; 2008 Jun; 30(4):197-206. PubMed ID: 17949947
[TBL] [Abstract][Full Text] [Related]
11. The clinical and immunological significance of GAD-specific autoantibody and T-cell responses in type 1 diabetes.
Boettler T; Pagni PP; Jaffe R; Cheng Y; Zerhouni P; von Herrath M
J Autoimmun; 2013 Aug; 44():40-8. PubMed ID: 23770292
[TBL] [Abstract][Full Text] [Related]
12. T-cell mediated autoimmunity to the insulinoma-associated protein 2 islet tyrosine phosphatase in type 1 diabetes mellitus.
Dotta F; Dionisi S; Viglietta V; Tiberti C; Matteoli MC; Cervoni M; Bizzarri C; Marietti G; Testi M; Multari G; Lucentini L; Di Mario U
Eur J Endocrinol; 1999 Sep; 141(3):272-8. PubMed ID: 10474125
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens.
Durinovic-Belló I
Autoimmunity; 1998; 27(3):159-77. PubMed ID: 9609134
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-21-dependent modulation of T cell antigen receptor reactivity towards low affinity peptide ligands in autoreactive CD8(+) T lymphocytes.
Bobbala D; Orkhis S; Kandhi R; Ramanathan S; Ilangumaran S
Cytokine; 2016 Sep; 85():83-91. PubMed ID: 27300756
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of GAD65-specific CD4+ T cells in healthy and type 1 diabetic subjects.
Danke NA; Yang J; Greenbaum C; Kwok WW
J Autoimmun; 2005 Dec; 25(4):303-11. PubMed ID: 16249070
[TBL] [Abstract][Full Text] [Related]
16. Low-avidity recognition by CD4+ T cells directed to self-antigens.
Gebe JA; Falk BA; Rock KA; Kochik SA; Heninger AK; Reijonen H; Kwok WW; Nepom GT
Eur J Immunol; 2003 May; 33(5):1409-17. PubMed ID: 12731068
[TBL] [Abstract][Full Text] [Related]
17. Autoreactive T cells in human type 1 diabetes.
Tree TI; Peakman M
Endocrinol Metab Clin North Am; 2004 Mar; 33(1):113-33, ix-x. PubMed ID: 15053898
[No Abstract] [Full Text] [Related]
18. GAD-alum treatment induces GAD65-specific CD4+CD25highFOXP3+ cells in type 1 diabetic patients.
Hjorth M; Axelsson S; Rydén A; Faresjö M; Ludvigsson J; Casas R
Clin Immunol; 2011 Jan; 138(1):117-26. PubMed ID: 21044870
[TBL] [Abstract][Full Text] [Related]
19. Targeting the trimolecular complex.
Michels AW
Clin Immunol; 2013 Dec; 149(3):339-44. PubMed ID: 23537861
[TBL] [Abstract][Full Text] [Related]
20. Avidity-dependent programming of autoreactive T cells in T1D.
Durinovic-Belló I; Gersuk VH; Ni C; Wu R; Thorpe J; Jospe N; Sanda S; Greenbaum CJ; Nepom GT
PLoS One; 2014; 9(5):e98074. PubMed ID: 24844227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
